Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Calithera Biosciences Inc
CALA | US
0.00
USD0.00
200.00%
CALA | US
Loading StockChartView...
About Calithera Biosciences Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
31/12/2022
As of date
24/04/2026
Close
0.00
Open
0.00
High
0.00
Low
0.00
Calithera Biosciences Inc. operates under a plan of liquidation that was approved in January 2023. Previously the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences Inc. was incorporated in 2010 and is headquartered in South San Francisco California.
View LessCALA | US
Risk
1979.9
Sharpe
0
Luna's Score
54/100
Recommendation
Hold
Luna says (CALA | US)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
2181.7%1 month
1979.9%3 months
1747.4%6 months
1248.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.07
Debt to equity
0.08
Debt to assets
0.06
Ent. to EBITDA
0.18
Ent. to rev.
0.01
PEG
-0.29
Other Fundamentals
EBITDA
-41.82M
MarketCap
1.46K
MarketCap(USD)
1.46K
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-114.14
Short ratio
0.78
Short perc.
8.92
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.00
Range1M
0.00
Range3M
0.00
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.59
Price X volume
0.09
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.18 | 0.53 | Cheaper |
| Ent. to Revenue | 0.01 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.07 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 1,747.38 | 72.80 | Riskier |
| Debt to Equity | 0.08 | -1.23 | Expensive |
| Debt to Assets | 0.06 | 0.25 | Cheaper |
| Market Cap | 1.46K | 3.66B | Emerging |
